Hi. Today I am going to discuss the Endocrine Society guidelines[1] for the use of devices in the treatment of diabetes. I was fortunate enough to be the chairwoman for this committee and it was a wonderful experience, in part because I had such great committee members with whom I worked.
The bottom line of our recommendation was not only that technology is advancing, but that there are tools that should be available to most patients with type 1 diabetes and some patients with type 2 diabetes.
The fundamental premise that we all came to is the true need for patients to have access to continuous glucose monitoring. This is a monitor that is placed on the patient's body for about a week and gives a signal with interstitial blood glucose levels to a receiver (it could be an iPhone or a pump) so that patients can see their blood glucose levels every 5 minutes and see the trends as blood sugar levels rise and fall.
I am at the point where I use these so much with my type 1 diabetes patients that I almost have a problem not having a patient bring me their sensor data. Back in the old days, we used to think that everybody should have finger sticks and bring their finger-stick data in.
COMMENTARY
'We Need to Move Forward': Continuous Glucose Monitoring in Diabetes
Anne L. Peters, MD
DisclosuresNovember 07, 2016
Hi. Today I am going to discuss the Endocrine Society guidelines[1] for the use of devices in the treatment of diabetes. I was fortunate enough to be the chairwoman for this committee and it was a wonderful experience, in part because I had such great committee members with whom I worked.
The bottom line of our recommendation was not only that technology is advancing, but that there are tools that should be available to most patients with type 1 diabetes and some patients with type 2 diabetes.
The fundamental premise that we all came to is the true need for patients to have access to continuous glucose monitoring. This is a monitor that is placed on the patient's body for about a week and gives a signal with interstitial blood glucose levels to a receiver (it could be an iPhone or a pump) so that patients can see their blood glucose levels every 5 minutes and see the trends as blood sugar levels rise and fall.
I am at the point where I use these so much with my type 1 diabetes patients that I almost have a problem not having a patient bring me their sensor data. Back in the old days, we used to think that everybody should have finger sticks and bring their finger-stick data in.
Medscape Diabetes © 2016 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: 'We Need to Move Forward': Continuous Glucose Monitoring in Diabetes - Medscape - Nov 07, 2016.
Tables
References
Authors and Disclosures
Authors and Disclosures
Author
Anne L. Peters, MD
Professor of Clinical Medicine; Director, Clinical Diabetes Programs, Keck School of Medicine, University of Southern California, Los Angeles, California
Disclosure: Anne L. Peters, MD, has disclosed the following financial relationships:
Served as director, officer, partner, employee, advisor, consultant, or trustee for: (current consultant): Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk
Served as a speaker or member of a speaker's bureau for: (current speakers bureau member): Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk; Takeda Pharmaceuticals North America, Inc.
Served as a consultant or ad hoc speaker/consultant for: AstraZeneca Pharmaceuticals LP; Abbott Laboratories; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Dexcom; Medtronic MiniMed, Inc.; Merck & Co., Inc.; Roche; sanofi-aventis